SCHEMBL493787

SCHEMBL493787

CC(C)(C)c1cc2c(c(C(C)(C)C)c1)OC(=O)C2c1ccc(OCCO)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.37
CYP3A4 P08684 1/20 0.37
GABBR2 O75899 1/20 0.36
GABBR1 Q9UBS5 1/20 0.36
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA9 Q16790 1/20 0.35
NR1I2 O75469 1/20 0.34
ALDH1A1 P00352 3/20 0.34
HPGD P15428 1/20 0.34
ALDH2 P05091 2/20 0.33
MAOA P21397 1/20 0.33
MAOB P27338 1/20 0.33
KDM4E B2RXH2 2/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
PPARG P37231 3/20 0.32
PPARA Q07869 1/20 0.32
ESR1 P03372 2/20 0.32
ESR2 Q92731 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29478052 1.00 SMN1; SMN2 (0.37) SMN1; SMN2CYP3A4GABBR2GABBR1CA12
SCHEMBL13525828 0.94 ALDH2 (0.36) SMN1; SMN2CYP3A4GABBR2GABBR1CA12
SCHEMBL18497002 0.94 ALDH2 (0.36) SMN1; SMN2CYP3A4GABBR2GABBR1CA12
SCHEMBL30172563 0.94 ALDH2 (0.36) SMN1; SMN2CYP3A4GABBR2GABBR1CA12
SCHEMBL26459763 0.93 ALDH1A1 (0.36) SMN1; SMN2CYP3A4GABBR2GABBR1ALDH1A1
SCHEMBL26459778 0.92 ALDH1A1 (0.35) SMN1; SMN2CYP3A4GABBR2GABBR1ALDH1A1
SCHEMBL26459779 0.91 ALDH1A1 (0.35) SMN1; SMN2GABBR2GABBR1ALDH1A1HPGD
SCHEMBL26459782 0.91 ALDH1A1 (0.35) SMN1; SMN2GABBR2GABBR1ALDH1A1HPGD
SCHEMBL26459777 0.89 ALDH1A1 (0.36) SMN1; SMN2CYP3A4GABBR2GABBR1ALDH1A1
SCHEMBL2237249 0.89 GABBR2 (0.34) SMN1; SMN2GABBR2GABBR1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 179 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117203271-A Use of a stabilizer composition for stabilizing halogen-free thermoplastic recycling material, a stabilizer composition, a masterbatch or concentrate, a stabilized plastic composition, a method for stabilizing halogen-free thermoplastic recycling material and use of a composition 弗劳恩霍夫应用研究促进协会 2023-12-08 CN claimed
EP-4745198-A1 RESIN COMPOSITION, MOLDED ARTICLE, RESIN ADDITIVE COMPOSITION, METHOD FOR PRODUCING RESIN COMPOSITION, METHOD FOR IMPROVING CRYSTALLINITY OF CRYSTALLINE RESIN, AND MATERIAL FOR RESIN ADDITIVE COMPOSITION ADEKA CORPORATION (JP) 2026-05-20 EP disclosed
US-20260109838-A1 CO-STABILIZERS FOR HYDROXYPHENYL TRIAZINE STABILIZED POLYMERS BASF SE (DE) 2026-04-23 US disclosed
US-20260092163-A1 FLAME-RETARDANT COMPOSITION, FLAME-RETARDANT RESIN COMPOSITION, AND MOLDED PRODUCT ADEKA CORPORATION (JP) 2026-04-02 US disclosed
EP-4632041-A1 FLAME-RETARDANT COMPOSITION, FLAME-RETARDANT RESIN COMPOSITION AND MOLDED ARTICLE ADEKA CORPORATION (JP) 2025-10-15 EP disclosed
EP-3904446-B1 NUCLEATING AGENT FOR POLYOLEFIN RESIN, NUCLEATING AGENT COMPOSITION FOR POLYOLEFIN RESIN CONTAINING SAME, MASTER BATCH FOR POLYOLEFIN RESIN, POLYOLEFIN RESIN COMPOSITION, MOLDED ARTICLE THEREOF, FILM THEREOF, METHOD FOR PRODUCING POROUS FILM, AND PACKAGE ADEKA CORP (JP) 2025-07-30 EP disclosed
US-20250163227-A1 NUCLEATING AGENT FOR POLYOLEFIN RESIN, NUCLEATING AGENT COMPOSITION FOR POLYOLEFIN RESIN CONTAINING SAME, MASTER BATCH FOR POLYOLEFIN RESIN, POLYOLEFIN RESIN COMPOSITION, MOLDED ARTICLE THEREOF, FILM THEREOF, METHOD FOR PRODUCING POROUS FILM, AND PACKAGE ADEKA CORPORATION (JP) 2025-05-22 US disclosed
US-12234332-B2 Nucleating agent for polyolefin resin, nucleating agent composition for polyolefin resin containing same, master batch for polyolefin resin, polyolefin resin composition, molded article thereof, film thereof, method for producing porous film, and package ADEKA CORPORATION (JP) 2025-02-25 US disclosed
WO-2025013891-A1 RESIN COMPOSITION, MOLDED ARTICLE, RESIN ADDITIVE COMPOSITION, METHOD FOR PRODUCING RESIN COMPOSITION, METHOD FOR IMPROVING CRYSTALLINITY OF CRYSTALLINE RESIN, AND MATERIAL FOR RESIN ADDITIVE COMPOSITION 株式会社ADEKA 2025-01-16 WO disclosed
US-20240360295-A1 STABILIZER COMBINATION FOR PREVENTING DEGRADATION OF SYNTHETIC POLYMERS BASF SE (DE) 2024-10-31 US disclosed
CN-1177608-A Stabilizer composition CIBA GEIGY CO LTD (CH) 1998-04-01 CN disclosed
CN-1036928-C Oligomeric HALS phosphites and HALS phosphonites as stabilisers CIBA SPECIAL CHEMICAL CO LTD (CH) 1998-01-07 CN disclosed
CN-1163921-A Stabilizer combination CIBA GEIGY AG (CH) 1997-11-05 CN disclosed
CN-1163283-A Synergistic mixture consisting of 2,4-dimethyl-6-S-alkylphenol and sterically hindered phenol CIBA GEIGY AG (CH) 1997-10-29 CN disclosed
CN-1132747-A Bisresorcinyltriazines CIBA GEIGY AG (CH) 1996-10-09 CN disclosed
CN-1132763-A Low-dust granules of plastic additives CIBA GEIGY AG (CH) 1996-10-09 CN disclosed
US-5428162-A For protecting organic materials against thermal, oxidative or light-induced degradation CIBA-GEIGY CORPORATION (US) 1995-06-27 US disclosed
US-5412088-A 6-O-substituted guanosine derivatives RUTGERS, THE STATE UNIVERSITY (US) 1995-05-02 US disclosed
CN-1092785-A Oligomeric HALS phosphorous acid ester and HALS phosphinate with used as stabilizers CIBA GEIGY AG (CH) 1994-09-28 CN disclosed
EP-0591102-A1 3-(2-Acyloxyethoxyphenyl)benzofuran-2-ones as stabilizers CIBA-GEIGY AG (CH) 1994-04-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250163227-A1 NUCLEATING AGENT FOR POLYOLEFIN RESIN, NUCLEATING AGENT COMPOSITION FOR POLYOLEFIN RESIN CONTAINING SAME, MASTER BATCH FOR POLYOLEFIN RESIN, POLYOLEFIN RESIN COMPOSITION, MOLDED ARTICLE THEREOF, FILM THEREOF, METHOD FOR PRODUCING POROUS FILM, AND PACKAGE NXF1, TAF1, RTF1 SMN1; SMN2 1005/4885CYP3A4 4772/4885GABBR2 3854/4885
US-12234332-B2 Nucleating agent for polyolefin resin, nucleating agent composition for polyolefin resin containing same, master batch for polyolefin resin, polyolefin resin composition, molded article thereof, film thereof, method for producing porous film, and package NXF1, TAF1, RTF1 SMN1; SMN2 1005/4885CYP3A4 4772/4885GABBR2 3854/4885
US-20260092163-A1 FLAME-RETARDANT COMPOSITION, FLAME-RETARDANT RESIN COMPOSITION, AND MOLDED PRODUCT PHOSPHO1, PAF1, PPA1 SMN1; SMN2 556/4885CYP3A4 4686/4885GABBR2 1127/4885
US-20260109838-A1 CO-STABILIZERS FOR HYDROXYPHENYL TRIAZINE STABILIZED POLYMERS CBR1, H1-2, HMOX1 SMN1; SMN2 1576/4885CYP3A4 955/4885GABBR2 3234/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.